ASX - Delayed Quote • AUD
Control Bionics Limited (CBL.AX)
At close: April 26 at 1:59 PM GMT+10
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.04 | 0 |
| Low Estimate | 0 | 0 | -0.04 | 0 |
| High Estimate | 0 | 0 | -0.04 | 0 |
| Year Ago EPS | -- | -- | -0.06 | -0.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.2M | 10.2M |
| Low Estimate | -- | -- | 6.2M | 10.2M |
| High Estimate | -- | -- | 6.2M | 10.2M |
| Year Ago Sales | -- | -- | 5.64M | 6.2M |
| Sales Growth (year/est) | -- | -- | 9.90% | 64.50% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.04 | 0 |
| 7 Days Ago | 0 | 0 | -0.04 | -0.02 |
| 30 Days Ago | 0 | 0 | -0.04 | -0.02 |
| 60 Days Ago | 0 | 0 | -0.04 | -0.02 |
| 90 Days Ago | 0 | 0 | -0.04 | -0.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CBL.AX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | 33.30% | -- | -- | 4.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
LBT.AX LBT Innovations Limited
0.0200
+5.26%
CYC.AX Cyclopharm Limited
1.7500
0.00%
UCM.AX Uscom Limited
0.0310
0.00%
RSH.AX Respiri Limited
0.0340
+3.03%
TRU.AX TruScreen Group Limited
0.0190
+18.75%
CMP.AX Compumedics Limited
0.2500
-3.85%
HMD.AX HeraMED Limited
0.0170
0.00%
IRX.AX InhaleRx Limited
0.0280
0.00%
CSX.AX CleanSpace Holdings Limited
0.3300
0.00%
VTI.AX Visioneering Technologies, Inc.
0.1350
-6.90%